Cargando…
PPARβ/δ-Interfering Peptide Enhanced Mesenchymal Stromal Cell Immunoregulatory Properties
BACKGROUND: Mesenchymal stem/stromal cells (MSCs) have been widely used for their therapeutic properties in many clinical applications including osteoarthritis. Despite promising preclinical results showing the ability of MSC to reduce the clinical severity of osteoarthritis (OA) in experimental ani...
Autores principales: | Tejedor, Gautier, Boisguerin, Prisca, Vivès, Éric, Jorgensen, Christian, Guicheux, Jérôme, Vinatier, Claire, Gondeau, Claire, Djouad, Farida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767714/ https://www.ncbi.nlm.nih.gov/pubmed/36561277 http://dx.doi.org/10.1155/2022/5494749 |
Ejemplares similares
-
PPARβ/δ-dependent MSC metabolism determines their immunoregulatory properties
por: Contreras-Lopez, R. A., et al.
Publicado: (2020) -
PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury
por: Sarre, Charlotte, et al.
Publicado: (2022) -
Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury
por: Sarre, Charlotte, et al.
Publicado: (2022) -
PPARβ/δ Is Required for Mesenchymal Stem Cell Cardioprotective Effects Independently of Their Anti-inflammatory Properties in Myocardial Ischemia-Reperfusion Injury
por: Nernpermpisooth, Nitirut, et al.
Publicado: (2021) -
Mechanisms behind the Immunoregulatory Dialogue between Mesenchymal Stem Cells and Th17 Cells
por: Terraza-Aguirre, Claudia, et al.
Publicado: (2020)